These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31521641)

  • 21. [Possibilities of material contamination due to additional injections].
    Müller-Stock A
    Klin Anasthesiol Intensivther; 1977; (14):114-20. PubMed ID: 926677
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possibilities of material contamination due to additional injections].
    Mehrkens HH; Klaus E; Schmitz JE
    Klin Anasthesiol Intensivther; 1977; (14):106-13. PubMed ID: 926676
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimization of Infrared Microscopy to Assess Secondary Structure of Insulin Molecules Within Individual Subvisible Particles in Aqueous Formulations.
    Schack MM; Møller EH; Friderichsen AV; Carpenter JF; Rades T; Groenning M
    J Pharm Sci; 2019 Mar; 108(3):1117-1129. PubMed ID: 30773199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automatic particle counters used for regulatory monitoring of particulates in LVPs: statistical analysis.
    Oxborrow GS; Nierman ML; Heisick JE; Lanier JM
    J Parenter Sci Technol; 1981; 35(5):237-41. PubMed ID: 7299600
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of Particle Techniques for the Characterization of Subvisible Particles From Elastomeric Closure Components.
    Rech J; Fradkin A; Krueger A; Kraft C; Paskiet D
    J Pharm Sci; 2020 May; 109(5):1725-1735. PubMed ID: 32017902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An approach to setting particulate matter standards for small volume parenterals.
    DeLuca PP; Boddapati S; Haack D; Schroeder H
    J Parenter Sci Technol; 1986; 40(1):2-13. PubMed ID: 3701538
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring of subvisible particles in therapeutic proteins.
    Singh SK; Toler MR
    Methods Mol Biol; 2012; 899():379-401. PubMed ID: 22735966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parameter for assessing parenteral cleanliness based on particle-size distributions.
    Blanchard J; Schwartz JA; Byrne DM
    J Pharm Sci; 1977 Aug; 66(8):1083-6. PubMed ID: 894493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products.
    Zhang L; Shi S; Antochshuk V
    J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality Control-Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding.
    Allen LV
    Int J Pharm Compd; 2018; 22(3):206-217. PubMed ID: 29878889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Particulate impurities in cell-based medicinal products traced by flow imaging microscopy combined with deep learning for image analysis.
    Grabarek AD; Senel E; Menzen T; Hoogendoorn KH; Pike-Overzet K; Hawe A; Jiskoot W
    Cytotherapy; 2021 Apr; 23(4):339-347. PubMed ID: 32507606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteremia outbreak tied to improper filtration by compounding pharmacy.
    Thompson CA
    Am J Health Syst Pharm; 2011 Nov; 68(22):2110, 2112. PubMed ID: 22058094
    [No Abstract]   [Full Text] [Related]  

  • 35. Good manufacturing in All in One compounding.
    Delanghe M
    Nutrition; 1989; 5(5):352-4. PubMed ID: 2520326
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hygienic standard of parenteral solutions.
    Winding O
    Ugeskr Laeger; 1977 Dec; 139(49):2940-4. PubMed ID: 595183
    [No Abstract]   [Full Text] [Related]  

  • 38. Minimizing waste of prepared sterile products.
    Davis NM
    Hosp Pharm; 1985 Feb; 20(2):109-13, 117. PubMed ID: 10270310
    [No Abstract]   [Full Text] [Related]  

  • 39. A model particulate research laboratory: I. Characterization of glass for parenteral products.
    Scothorn WW; Roseman TJ; Hamlin WE
    Bull Parenter Drug Assoc; 1976; 30(3):105-17. PubMed ID: 1268429
    [No Abstract]   [Full Text] [Related]  

  • 40. [Parenteral administration medicines: recommendations of preparation, administration and stability].
    Gaspar Carreño M; Torrico Martín F; Novajarque Sala L; Batista Cruz M; Ribeiro Gonçalves P; Porta Oltra B; Sánchez Santos JC
    Farm Hosp; 2014 Nov; 38(6):461-7. PubMed ID: 25542656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.